HIV/AIDS Stem Cell Clinical Trial: Introduction by Jeff Sheehy
On July 9th 2013, Calimmune announced they had treated the first patient in a clinical trial involving the use of an innovative gene-based stem cell therapy to help protect individuals…
On July 9th 2013, Calimmune announced they had treated the first patient in a clinical trial involving the use of an innovative gene-based stem cell therapy to help protect individuals…
On July 9th 2013, Calimmune announced they had treated the first patient in a clinical trial involving the use of an innovative gene-based stem cell therapy to help protect individuals…
On July 9th 2013, Calimmune announced they had treated the first patient in a clinical trial involving the use of an innovative gene-based stem cell therapy to help protect individuals…
Paula Cannon speaks at the 2011 CIRM Grantee Meeting about a stem cell-based therapy for HIV/AIDS. Cannon is a co-principle investigator on a disease team that has the goal of…
CIRM has funded two HIV/AIDS Disease Teams led by scientists at UCLA and the City of Hope who are focused on stem cell transplant strategies that promise a long lasting…
Spotlight on HIV/AIDS: Jeff Sheehy Jeff Sheehy, spoke at the "Spotlight on Disease Team Awards: HIV/AIDS," an educational event presented at the CIRM Governing Board meeting on April 29, 2010.…
Spotlight on HIV/AIDS: John Zaia John Zaia, M.D., spoke at the "Spotlight on Disease Team Awards: HIV/AIDS," an educational event presented at the CIRM Governing Board meeting on April 29,…
Spotlight on HIV/AIDS: Loring Leeds Loring Leeds, spoke at the "Spotlight on Disease Team Awards: HIV/AIDS," an educational event presented at the CIRM Governing Board meeting on April 29,…
Donald Francis, M.D., D.Sc., spoke at the Scientific Writer's Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. Francis provided a perspective of the current…